A schedule of events for MALDI-Mass Spectrometry Imaging of Drug Metabolism is provided below for your convenience.
This is a one-day conference scheduled for Tuesday, April 8, 2014 at the University of Maryland School of Pharmacy, located at 20 N. Pine Street in Baltimore, MD. The conference is open to the public. Download a printer-friendly version of the agenda here.
| Time | Activity |
|---|---|
| 9:00-10:00 a.m. | Registration and Light Breakfast |
| 10:00-10:15 a.m. | Welcome and Introduction |
| 10:15-10:55 a.m. | MALDI Imaging Mass Spectrometry: A View of Biology and Chemistry in Drug Development Stephen Castellino, PhD US Director of Structal ID DMPK GlaxoSmith Kline |
| 10:55-11:35 a.m. | Mass Spectrometry Imaging in Drug Development Per Andren, PhD Senior Lecturer, Department of Pharmaceutical Biosciences University of Uppsala Uppsala, Sweden |
| 11:35-12:15 p.m. | MALDI-MS Tissue Imaging in Infectious Disease Research: Exploring Alternative Fixation Methods for the Inactivation of Pathogens Lisa Cazares, PhD Proteomic Scientist Army Research Institute of Infectious Disease (USAMRIID) |
| 12:15-1:15 p.m. | Lunch |
| 1:15-1:55 p.m. | Mass Spectrometry Imaging Applications to Tuberculosis Drug Discovery and Development Brendan Prideaux, PhD Visiting Researcher The Public Health Research Institute (PHRI) Rutgers New Jersey Medical School |
| 1:55-2:35 p.m. | MALDI-Mass Spectrometry Imaging in the Development of Medical Countermeasures Against Radiological Threat Maureen Kane, PhD Assistant Professor Department of Pharmaceutical Sciences University of Maryland School of Pharmacy |
| 2:35-3:15 p.m. | Imaging Mass Spectrometry: Applications Supporting Drug Discovery and Development Michelle L. Reyzer, PhD Research Assistant Professor of Biochemistry Vanderbilt University |
| 3:15-3:45 p.m. | Panel and Audience Discussion Topic: Status of MALDI-MSI Adoption as a Drug Development Tool |
| 3:45-4:00 p.m. | Closing Remarks |